LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Boston Scientific Corp.

Cerrado

Sector Salud

81.59 0.31

Resumen

Variación precio

24h

Actual

Mínimo

81.29

Máximo

81.65

Métricas clave

By Trading Economics

Ingresos

-168M

324M

Ventas

260M

4.1B

P/B

Media del Sector

64.71

103.001

BPA

0.62

Margen de beneficio

7.864

Empleados

48,000

EBITDA

-173M

808M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+7.67 upside

Dividendos

By Dow Jones

Próximas Ganancias

24 oct 2024

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

617M

120B

Apertura anterior

81.28

Cierre anterior

81.59

Noticias sobre sentimiento de mercado

By Acuity

30%

70%

56 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Boston Scientific Corp. Gráfico

Noticias Relacionadas

18 jun 2024, 13:23 UTC

Adquisiciones, fusiones, absorciones

Correction to Boston Scientific to Buy Silk Road Article

18 jun 2024, 11:41 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Silk Road Medical Shares Surge Premarket on Boston Scientific Deal

18 jun 2024, 11:31 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

24 abr 2024, 11:01 UTC

Ganancias

Boston Scientific Lifts 2024 Outlook After Strong 1Q

24 jul 2024, 12:02 UTC

Ganancias

Boston Scientific Earnings Beat; Medtech Giant Raises Guidance -- IBD

24 jul 2024, 10:48 UTC

Ganancias

Boston Scientific Profit Beats Estimates As Cardiovascular Sales Surge -- MarketWatch

24 jul 2024, 10:47 UTC

Ganancias

GE Vernova Delivers An Earnings Beat With First Results After Separation, Even As Revenue Misses -- MarketWatch

24 jul 2024, 10:47 UTC

Ganancias

Boston Scientific Earnings Beat, Guidance Raised; Medtech Giant Rises -- IBD

24 jul 2024, 10:33 UTC

Ganancias

Boston Scientific Sees 3Q Net Sales Growth of About 13%-15% >BSX

24 jul 2024, 10:32 UTC

Ganancias

Boston Scientific Sees FY Net Sales Growth of About 13.5%-14.5% >BSX

24 jul 2024, 10:30 UTC

Ganancias

Boston Scientific Sees FY EPS $1.34-EPS $1.38 >BSX

24 jul 2024, 10:30 UTC

Ganancias

Boston Scientific Sees FY Adj EPS $2.38-Adj EPS $2.42 >BSX

24 jul 2024, 10:30 UTC

Ganancias

Boston Scientific 2Q Adj EPS 62c >BSX

24 jul 2024, 10:30 UTC

Ganancias

Boston Scientific 2Q EPS 22c >BSX

24 jul 2024, 10:30 UTC

Ganancias

Boston Scientific Sees 3Q Adj EPS 57c-Adj EPS 59c >BSX

24 jul 2024, 10:30 UTC

Ganancias

Boston Scientific Sees 3Q EPS 36c-EPS 38c >BSX

24 jul 2024, 10:30 UTC

Ganancias

Boston Scientific 2Q Sales $4.12B >BSX

18 jun 2024, 20:22 UTC

Adquisiciones, fusiones, absorciones

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 jun 2024, 14:25 UTC

Adquisiciones, fusiones, absorciones

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 jun 2024, 12:54 UTC

Adquisiciones, fusiones, absorciones

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 jun 2024, 11:33 UTC

Adquisiciones, fusiones, absorciones

Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. -- Barrons.com

18 jun 2024, 11:18 UTC

Adquisiciones, fusiones, absorciones

Silk Road Medical Stock Rallies On Boston Scientific Acquisition Deal -- MarketWatch

18 jun 2024, 11:03 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific Sees Immaterial Impact to Adjusted EPS In 2024, 2025 >BSX

18 jun 2024, 11:02 UTC

Adquisiciones, fusiones, absorciones

Silk Road Medical to Be Acquired for $27.50/Share; Closed Monday at $21.67 >SILK BSX

18 jun 2024, 11:01 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific: Silk Road Medical Deal Reflects Enterprise Value of About $1.16 Billion >BSX SILK

18 jun 2024, 11:01 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific To Buy Silk Road Medical for $27.50/Share >BSX SILK

18 jun 2024, 11:00 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific Announces Agreement To Acquire Silk Road Medical, Inc. >BSX SILK

24 abr 2024, 12:30 UTC

Principales Noticias
Ganancias

Boston Scientific Stock Rises on More Than Just an Earnings Beat -- Barrons.com

24 abr 2024, 10:36 UTC

Ganancias

Boston Scientific Sees 2024 Sales Up 11%-13%, Organic Sales Up 10%-12% >BSX

24 abr 2024, 10:35 UTC

Ganancias

Boston Scientific Sees 2Q Sales Up 10.5%-12.5%, Organic Sales Up 10%-12% >BSX

Comparación entre iguales

Cambio de precio

Boston Scientific Corp. Esperado

Precio Objetivo

By TipRanks

7.67% repunte

Estimación a 12 meses

Media 87.61 USD  7.67%

Máximo 100 USD

Mínimo 78 USD

De acuerdo con 19 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Boston Scientific Corp. Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

19 ratings

18

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

79.9 / 81.79Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

56 / 365 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.